Abpro IPO
Abpro leverages synthetic biology and immunology to accelerate antibody discovery and development in the life sciences industry.
Abpro leverages synthetic biology and immunology to accelerate antibody discovery and development in the life sciences industry.
Abpro is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Abpro is privately held company and is not publicly traded, therefor investing in Abpro pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.
To determine the value of your Abpro shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Abpro shares. You can also learn more about how to sell your private shares before getting started.
Yes, you can seek to sell shares in Abpro while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 3/30/2022 | Series F |
$2MM raised | $XXX.XX | $XXX.XX |
| 3/3/2020 | Series E |
$30MM raised | $XXX.XX | $XXX.XX |
| 1/15/2020 | Series D |
$18.2MM raised | $XXX.XX | $XXX.XX |
| 3/11/2016 | Series C |
$15.73MM raised | $XXX.XX | $XXX.XX |
| 8/11/2015 | Series B |
$1.8MM raised | $XXX.XX | $XXX.XX |
| 9/20/2007 | Series A |
$1.8MM raised | $XXX.XX | $XXX.XX |
